<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02812095</url>
  </required_header>
  <id_info>
    <org_study_id>1407-193-601</org_study_id>
    <nct_id>NCT02812095</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Refeeding in Preterm Infants With Enterostomy</brief_title>
  <official_title>Efficacy and Safety of Refeeding in Preterm Infants With Enterostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Refeeding is an extracorporeal stool transport from the proximal stoma end to the distal end&#xD;
      of stoma. Refeeding may be beneficial in preventing malabsorption, electrolyte imbalance,&#xD;
      cholestasis and atrophy of the distal intestine. Investigators are focused on evaluating the&#xD;
      efficacy and safety of the practice of refeeding in preterm infants with enterostomy.&#xD;
      Clinical data including weight gain, total parenteral nutrition (TPN) usage, and other&#xD;
      laboratory findings will be collected. Serial citrulline levels during refeeding procedure&#xD;
      and pathologic specimens of bowel (at the time of stoma closure) will be collected for&#xD;
      evaluating bowel adaptation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">April 16, 2020</completion_date>
  <primary_completion_date type="Actual">December 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of citrulline level during the study period</measure>
    <time_frame>up to 6 months of corrected age</time_frame>
    <description>4 time points: at the time of full enteral feeding (&gt;120 cc/kg/day), 4 weeks later after full enteral feeding, at the time of stoma closure operation, 12 weeks later after closure operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The pathologic findings after refeeding procedure</measure>
    <time_frame>up to 8 weeks of corrected age</time_frame>
    <description>villus height, crypt depth, mucosal thickening of pathologic specimens at the time of stoma closure operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of days on parenteral nutrition</measure>
    <time_frame>up to 8 weeks of corrected age</time_frame>
    <description>the day of discontinuation of intravenous protein supplements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The weight gain</measure>
    <time_frame>up to 6 months of corrected age</time_frame>
    <description>differences in the admission weight Z-scores and end of study weight Z-scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events during refeeding procedure</measure>
    <time_frame>up to 8 weeks of corrected age</time_frame>
    <description>bowel prolapse, enteral hemorrhage, abdominal distension, infection related stoma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Enterostomy</condition>
  <arm_group>
    <arm_group_label>The refeeding group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Refeeding is initiated when 120mL/kg/day of enteral feed reaches or stoma loss exceeds more than 40ml/kg/day after operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Refeeding</intervention_name>
    <description>when amount of feeding reach to 120mL/kg a day,</description>
    <arm_group_label>The refeeding group</arm_group_label>
    <other_name>extracorporeal stool transport</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preterm infants who are less than 35 weeks gestational age at birth and get stomas&#xD;
             after laparotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital gastrointestinal malformation&#xD;
&#xD;
          -  Blind pouch (after laparotomy)&#xD;
&#xD;
          -  Refeeding procedure related infection&#xD;
&#xD;
          -  Hemodynamic instability requiring inotropic or vasopressor agents (if the condition&#xD;
             improves, the refeeding procedure can be restarted again)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 6, 2016</study_first_submitted>
  <study_first_submitted_qc>June 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ee-Kyung Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

